Krka Farma, Ooo, headquartered in Russia, is a prominent player in the pharmaceutical industry, specialising in the development and production of high-quality generic medications. Founded in 2000, the company has established a strong presence in various operational regions, focusing on cardiovascular, central nervous system, and anti-infective therapies. With a commitment to innovation, Krka Farma offers a diverse portfolio of products that stand out for their efficacy and affordability. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to quality and patient care, Krka Farma continues to contribute to the healthcare landscape, making a meaningful impact on the lives of patients across Russia and beyond.
How does Krka Farma, Ooo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Krka Farma, Ooo's score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Krka Farma, Ooo, headquartered in Russia, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Krka, d. d., which may influence its climate commitments and reporting practices. As of now, Krka Farma has not established any documented reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. Given its affiliation with Krka, d. d., emissions data and performance metrics may be cascaded from this parent organization. However, without explicit figures or targets from Krka, d. d., it is challenging to provide a comprehensive overview of Krka Farma's carbon footprint or climate commitments. In summary, while Krka Farma, Ooo is part of a larger corporate family that may have climate initiatives, specific emissions data and reduction targets for the company itself are currently unavailable.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 66,245,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Krka Farma, Ooo has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.